WallStreetZenWallStreetZen

NASDAQ: IMDX
Insight Molecular Diagnostics Inc Stock Ownership - Who owns Insight Molecular Diagnostics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Insight Molecular Diagnostics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew ArnoDirector2026-07-0112,100$5.69
$68.85kSell
Andrew J. LastDirector2026-07-017,700$5.69
$43.81kSell
Lou SilvermanDirector2026-07-017,700$5.69
$43.81kSell
Broadwood Partners LP10% Owner2026-04-27250,923$3.64
$913.11kBuy
Broadwood Partners LP10% Owner2026-04-2438,880$3.53
$137.09kBuy
Broadwood Partners LP10% Owner2026-04-23280,381$3.50
$981.89kBuy
Broadwood Partners LP10% Owner2026-04-2040,690$3.88
$157.96kBuy
Broadwood Partners LP10% Owner2026-04-1740,114$3.57
$143.25kBuy
Broadwood Partners LP10% Owner2026-04-16102,057$3.45
$351.69kBuy
Andrea S. JamesChief Financial Officer2026-03-2611,298$4.11
$46.43kSell

1 of 2

IMDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMDX insiders and whales buy or sell their stock.

IMDX Shareholders

What type of owners hold Insight Molecular Diagnostics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pura Vida Investments LLC108.15%34,922,779$168.68MInsider
Broadwood Partners LP84.86%27,401,245$132.35MInsider
Broadwood Capital Inc36.95%11,931,839$57.63MInstitution
Lineage Cell Therapeutics Inc18.71%6,041,154$29.18MInsider
John Peter Gutfreund15.18%4,900,047$23.67MInsider
George Karfunkel11.33%3,659,860$17.68MInsider
Patrick W. Smith10.09%3,258,485$15.74MInsider
Awm Investment Company Inc8.69%2,806,256$13.55MInstitution
Pura Vida Investments LLC2.93%947,134$4.57MInstitution
Alyeska Investment Group LP2.60%840,777$4.06MInstitution

1 of 3

IMDX vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMDX18.52%81.48%Net BuyingNet Selling
STIM54.09%45.91%Net BuyingNet Buying
XGN39.93%46.74%Net Selling
BNR1.63%18.67%Net BuyingNet Buying
SERA50.93%25.77%Net SellingNet Selling
View Top Diagnostic & Research Stocks

Insight Molecular Diagnostics Stock Ownership FAQ

Who owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics (NASDAQ: IMDX) is owned by 58.65% institutional shareholders, 258.09% Insight Molecular Diagnostics insiders, and 0.00% retail investors. Pura Vida Investments LLC is the largest individual Insight Molecular Diagnostics shareholder, owning 34.92M shares representing 108.15% of the company. Pura Vida Investments LLC's Insight Molecular Diagnostics shares are currently valued at $166.58M.

If you're new to stock investing, here's how to buy Insight Molecular Diagnostics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.